Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $33.05 -8.85%
EPS Growth %: -27.8%
Financial Fact:
Cost of revenues: 1.63M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -27.8%
Financial Fact:
Cost of revenues: 1.63M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($1.26), $0.11 worse than the analyst estimate of ($1.15).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- General Mills beats estimates as cost savings offset volumes
- Everpure raises FY28 revenue outlook, targets four growth areas
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
